Injective vs Velo — how do they compare? Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,76T 24h volume), while Velo trades at Rp57.48 (market cap Rp1,01T, Rp42,45M 24h volume). The key difference: Injective is far larger — about 9.2× Velo's market cap, and Velo's supply is capped (17,6B / 24B VELO (74%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Velo for 27 Days on average.
| INJ | VELO | |
|---|---|---|
Market Cap | Rp9,29T | Rp1,01T |
Volume (24h) | Rp1,76T | Rp42,45M |
Circulating Supply | 100M INJ | 17,6B / 24B VELO (74%) |
Typical Hold Time | 36 Days | 27 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
VELO is currently trading at Rp58.16 with a market cap of Rp1.01T, showing bearish technical signals overall. The asset faces selling pressure with moving averages indicating a downtrend, though oscillators remain neutral. Current price sits near the pivot point of Rp57, with immediate resistance at Rp62 and support at Rp54. The token has 74% of its maximum 24M supply in circulation with an average hold time of 27 days.
Overall outlook remains cautious due to bearish technical indicators and limited fundamental developments. Key opportunities include potential breakout above Rp62 resistance, while risks include continued selling pressure and lack of significant network updates. Investors should monitor volume patterns and watch for any protocol developments that could drive adoption.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Velo Labs is building a unique federated credit exchange network. This network is powered by the Velo Protocol, which is a blockchain financial protocol enabling digital credit issuance and borderless asset transfers for businesses using a smart contract system. The project's core mission is to enable partners to safely and securely transfer value between each other in a timely and transparent way.
Read more on VELO →